How Cannabinoids Affect the Brain's Reward Center | Research

The takeaway

Cannabinoids strongly inhibited excitatory inputs to the nucleus accumbens shell, a key brain reward region, through CB1 receptors, independent of dopamine or opioid systems.

Read this if you want to understand the brain mechanisms behind why cannabis feels rewarding.

Cannabinoid reward effects independent of dopamine and opioid systems

What the researchers found

Synthetic cannabinoids (WIN 55212,2 and HU-210) and THC all strongly inhibited the firing of neurons in the shell of the nucleus accumbens when those neurons were activated by inputs from the basolateral amygdala or medial prefrontal cortex. This inhibition was completely blocked by the CB1 antagonist SR141716A, confirming it was CB1 receptor-mediated.

Neither dopamine receptor antagonists nor the opioid antagonist naloxone could reverse the cannabinoid effect, demonstrating that this mechanism was independent of both dopamine and opioid signaling. This was significant because the nucleus accumbens is a critical site for the rewarding properties of drugs of abuse.

Why it matters

The nucleus accumbens is central to how the brain processes reward and motivation. This study revealed that cannabinoids had a direct, receptor-specific effect on this region's excitatory inputs, separate from the dopamine system that most drugs of abuse target. This provided a mechanistic explanation for why cannabis has both rewarding properties and the potential for dependence.

The numbers in context

WIN 55212,2 doses: 0.062-0.25 mg/kg IV. HU-210: 0.125-0.25 mg/kg IV. THC: 1.0 mg/kg IV. SR141716A (CB1 antagonist): 0.5 mg/kg IV fully blocked the effect.

How the study worked

This was an in vivo electrophysiology study in anesthetized rats. Extracellular recordings were made from neurons in the nucleus accumbens shell while electrically stimulating the basolateral amygdala or medial prefrontal cortex. Various cannabinoid agonists and antagonists, along with dopamine and opioid receptor blockers, were administered intravenously.

What this study cannot tell us

The study was performed in anesthetized rats, which may alter neural dynamics. The doses used were administered intravenously, differing from typical human cannabis use. The relationship between inhibition of excitatory inputs to the nucleus accumbens and subjective reward experience was inferred rather than directly demonstrated.

How to read the evidence

This is a controlled animal electrophysiology study providing preliminary evidence of a specific neural mechanism.

When this study was published

Published in 2002. Subsequent studies have built on these findings to better understand cannabinoid reward circuitry.

The bigger picture

This study contributed to understanding cannabinoid reward mechanisms at a fundamental level. The finding that cannabinoid effects on the reward center were independent of dopamine and opioid systems suggested unique aspects of cannabis reward that differ from stimulants and opioids, helping explain why cannabis dependence has a distinct clinical profile.

Questions still open

How does this CB1-mediated inhibition of excitatory inputs relate to the subjective experience of cannabis reward? Does chronic cannabis use alter this mechanism in ways that contribute to dependence? Could this pathway be targeted to treat cannabis use disorder?

Common questions

Why do people find cannabis rewarding?

This study showed that cannabinoids directly inhibit excitatory inputs to the nucleus accumbens, the brain's reward center, through CB1 receptors. This is a distinct mechanism from how other drugs like cocaine (dopamine) or heroin (opioids) affect the same region.

Does cannabis affect the brain differently from other drugs?

Yes. This study found that cannabinoid effects on the reward center were not blocked by dopamine or opioid antagonists, suggesting a unique mechanism of action that may explain why cannabis dependence looks different from stimulant or opioid dependence.

Read the original research

Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.

The European journal of neuroscience, 15(11), 1795-802

View on PubMed ↗

Citation

Pistis, Marco; Muntoni, Anna Lisa; Pillolla, Giuliano; Gessa, Gian Luigi. (2002). Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens: an in vivo electrophysiological study.. The European journal of neuroscience, 15(11), 1795-802.